Abstract
A recent “secret shopper” study (a three paragraph research letter, actually) has found that only one in four residential treatment centers which treat opioid use disorder (OUD) in adolescents offer buprenorphine. According to the study, which is based on calls made to treatment centers listed on the federal Substance Abuse and Mental Health Services (SAMHSA) “treatment locator” website, these centers simply do not offer buprenorphine to adolescents.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: The Brown University Child and Adolescent Behavior Letter
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
